Nitric Oxide Donor-Based Cancer Therapy: Advances and Prospects
Тип публикации: Journal Article
Дата публикации: 2017-05-23
scimago Q1
wos Q1
БС1
SJR: 1.801
CiteScore: 11.5
Impact factor: 6.8
ISSN: 00222623, 15204804
PubMed ID:
28505442
Drug Discovery
Molecular Medicine
Краткое описание
The increasing understanding of the role of nitric oxide (NO) in cancer biology has generated significant progress in the use of NO donor-based therapy to fight cancer. These advances strongly suggest the potential adoption of NO donor-based therapy in clinical practice, and this has been supported by several clinical studies in the past decade. In this review, we first highlight several types of important NO donors, including recently developed NO donors bearing a dinitroazetidine skeleton, represented by RRx-001, with potential utility in cancer therapy. Special emphasis is then given to the combination of NO donor(s) with other therapies to achieve synergy and to the hybridization of NO donor(s) with an anticancer drug/agent/fragment to enhance the activity or specificity or to reduce toxicity. In addition, we briefly describe inducible NO synthase gene therapy and nanotechnology, which have recently entered the field of NO donor therapy.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Топ-30
Журналы
|
5
10
15
20
25
|
|
|
European Journal of Medicinal Chemistry
21 публикация, 6.03%
|
|
|
Journal of Medicinal Chemistry
16 публикаций, 4.6%
|
|
|
Molecules
10 публикаций, 2.87%
|
|
|
ACS applied materials & interfaces
9 публикаций, 2.59%
|
|
|
Chemical Engineering Journal
7 публикаций, 2.01%
|
|
|
Nitric Oxide - Biology and Chemistry
7 публикаций, 2.01%
|
|
|
Bioorganic Chemistry
6 публикаций, 1.72%
|
|
|
Journal of Materials Chemistry B
6 публикаций, 1.72%
|
|
|
Chemistry - A European Journal
5 публикаций, 1.44%
|
|
|
Antioxidants
5 публикаций, 1.44%
|
|
|
Bioorganic and Medicinal Chemistry Letters
5 публикаций, 1.44%
|
|
|
Journal of Molecular Structure
5 публикаций, 1.44%
|
|
|
Angewandte Chemie
5 публикаций, 1.44%
|
|
|
Angewandte Chemie - International Edition
5 публикаций, 1.44%
|
|
|
Nanoscale
5 публикаций, 1.44%
|
|
|
International Journal of Molecular Sciences
4 публикации, 1.15%
|
|
|
Biochemical Pharmacology
4 публикации, 1.15%
|
|
|
Journal of Controlled Release
4 публикации, 1.15%
|
|
|
Small
4 публикации, 1.15%
|
|
|
Advanced healthcare materials
4 публикации, 1.15%
|
|
|
Organic Letters
4 публикации, 1.15%
|
|
|
Chinese Chemical Letters
3 публикации, 0.86%
|
|
|
Nanomaterials
3 публикации, 0.86%
|
|
|
Nature Communications
3 публикации, 0.86%
|
|
|
Journal of Nanobiotechnology
3 публикации, 0.86%
|
|
|
Medicinal Chemistry Research
3 публикации, 0.86%
|
|
|
Acta Biomaterialia
3 публикации, 0.86%
|
|
|
Chinese Journal of Natural Medicines
3 публикации, 0.86%
|
|
|
Organic Chemistry Frontiers
3 публикации, 0.86%
|
|
|
5
10
15
20
25
|
Издатели
|
20
40
60
80
100
120
140
|
|
|
Elsevier
121 публикация, 34.77%
|
|
|
Wiley
51 публикация, 14.66%
|
|
|
American Chemical Society (ACS)
50 публикаций, 14.37%
|
|
|
MDPI
32 публикации, 9.2%
|
|
|
Royal Society of Chemistry (RSC)
30 публикаций, 8.62%
|
|
|
Springer Nature
25 публикаций, 7.18%
|
|
|
Frontiers Media S.A.
7 публикаций, 2.01%
|
|
|
Taylor & Francis
6 публикаций, 1.72%
|
|
|
Bentham Science Publishers Ltd.
5 публикаций, 1.44%
|
|
|
Mary Ann Liebert
2 публикации, 0.57%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
2 публикации, 0.57%
|
|
|
SAGE
2 публикации, 0.57%
|
|
|
Pleiades Publishing
2 публикации, 0.57%
|
|
|
Spandidos Publications
2 публикации, 0.57%
|
|
|
Media Sphere Publishing House
1 публикация, 0.29%
|
|
|
American Scientific Publishers
1 публикация, 0.29%
|
|
|
The Company of Biologists
1 публикация, 0.29%
|
|
|
Impact Journals
1 публикация, 0.29%
|
|
|
International Society of Pteridinology
1 публикация, 0.29%
|
|
|
SciELO
1 публикация, 0.29%
|
|
|
IntechOpen
1 публикация, 0.29%
|
|
|
Cold Spring Harbor Laboratory
1 публикация, 0.29%
|
|
|
Scientific and Practical Reviewed Journal Pulmonology
1 публикация, 0.29%
|
|
|
Georg Thieme Verlag KG
1 публикация, 0.29%
|
|
|
Beilstein-Institut
1 публикация, 0.29%
|
|
|
20
40
60
80
100
120
140
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.
Вы ученый?
Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Метрики
348
Всего цитирований:
348
Цитирований c 2024:
102
(29%)
Цитировать
ГОСТ |
RIS |
BibTex |
MLA
Цитировать
ГОСТ
Скопировать
Huang Z., Fu J., Zhang Y. Nitric Oxide Donor-Based Cancer Therapy: Advances and Prospects // Journal of Medicinal Chemistry. 2017. Vol. 60. No. 18. pp. 7617-7635.
ГОСТ со всеми авторами (до 50)
Скопировать
Huang Z., Fu J., Zhang Y. Nitric Oxide Donor-Based Cancer Therapy: Advances and Prospects // Journal of Medicinal Chemistry. 2017. Vol. 60. No. 18. pp. 7617-7635.
Цитировать
RIS
Скопировать
TY - JOUR
DO - 10.1021/acs.jmedchem.6b01672
UR - https://doi.org/10.1021/acs.jmedchem.6b01672
TI - Nitric Oxide Donor-Based Cancer Therapy: Advances and Prospects
T2 - Journal of Medicinal Chemistry
AU - Huang, Zhangjian
AU - Fu, Junjie
AU - Zhang, Yihua
PY - 2017
DA - 2017/05/23
PB - American Chemical Society (ACS)
SP - 7617-7635
IS - 18
VL - 60
PMID - 28505442
SN - 0022-2623
SN - 1520-4804
ER -
Цитировать
BibTex (до 50 авторов)
Скопировать
@article{2017_Huang,
author = {Zhangjian Huang and Junjie Fu and Yihua Zhang},
title = {Nitric Oxide Donor-Based Cancer Therapy: Advances and Prospects},
journal = {Journal of Medicinal Chemistry},
year = {2017},
volume = {60},
publisher = {American Chemical Society (ACS)},
month = {may},
url = {https://doi.org/10.1021/acs.jmedchem.6b01672},
number = {18},
pages = {7617--7635},
doi = {10.1021/acs.jmedchem.6b01672}
}
Цитировать
MLA
Скопировать
Huang, Zhangjian, et al. “Nitric Oxide Donor-Based Cancer Therapy: Advances and Prospects.” Journal of Medicinal Chemistry, vol. 60, no. 18, May. 2017, pp. 7617-7635. https://doi.org/10.1021/acs.jmedchem.6b01672.
Профили